It appears that Ahz has quickly gone from the darling of the ASX small cap to the ugly duckling. Hard to fathom that a stock that was 18.5 when the ASX was around 5000 is struggling to get off 11 when the ASX is about to touch 6000. Even worse, the Nasdaq biotech index has also surged over the past twelve months. Something's not right here....maybe investors don't think that ADAPT can bring in the money without massive costs involved. With the way AHZ is setup at the moment, it's hard to see where they will get the cash in a short timeframe. Maybe it's time to thnk about partnering up?
real competition?..., page-12
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |